Peter Svennilson - 28 May 2021 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: RAPT
Reported as of: 28 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jun 2021, 20:12:13 UTC
Next SEC filing: 17 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Rodney Young, Attorney-in-Fact for Peter Svennilson

Key filing fact

Peter Svennilson filed Form 4 for RAPT Therapeutics, Inc. (RAPT) on 24 Jun 2021.

Key facts

This page summarizes Peter Svennilson's Form 4 filing for RAPT Therapeutics, Inc. (RAPT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Jun 2021, 20:12.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RAPT transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +7,500
Change %
Price: $0.000000
Shares after: 7,500
Date: 28 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $19.30
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Option shall vest on the earlier of (i) May 28, 2022, or (ii) one day prior to the date of the Issuer's next annual meeting of stockholders to be held in 2022, subject to the Reporting Person's continuous service through each applicable vesting date.